Star Imaging and Path Lab Ltd IPO
Open Demat Account
Star Imaging and Path Lab Ltd IPO Details
Details
Total Shares Offered | Offer to Public | Retail Max (Shares) | Pre Issue Promoters Holding | Exchange | Issue size |
---|---|---|---|---|---|
₹ 48.92 L | ₹ 9.72 L | TBA | ₹ 158.5 L | BSE | ₹ 69.47 Cr |
IPO Open Date | Close Date | Lot Size | Min Investment | Issue Type | Listing Date |
08 Aug, 25 | 12 Aug, 25 | 2000 | ₹ 2,70,000 | Book Building - SME | 18 Aug, 25 |
Star Imaging and Path Lab Ltd IPO Dates
Details
Sector | Type |
---|---|
Sector | Healthcare |
Sub Sector | NA |
Issue Type | Book Building - SME |
Subscription Status
*Values are in Lakhs
Investor Type | Subscription Times | Shares Offered* | Shares Bid* |
---|---|---|---|
QIB | 0x | 0 | 0 |
NII | 0x | 0 | 0 |
Retail | 0x | 0 | 0 |
Employee | 0x | 0 | 0 |
Total | 0x | 4892000 | 0 |
Subscription Status
Investor Type
QIB
NII
Retail
Employee
Total
*Values are in Lakhs
Star Imaging and Path Lab Ltd Financial Status
Income Statement
Balance Sheet
Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
---|---|---|---|
Revenue from operations | 21.25 | 4.22 | 12.91 |
EBITDA | 26.49 | 7.56 | 16.42 |
PAT | 12.34 | 0.57 | 6.30 |
Total Assets | 53.07 | 26.11 | 31.51 |
Share Capital | 1.50 | 1.50 | 1.50 |
Total Borrowings | 15.93 | 16.48 | 18.04 |
Operating Activities (Net Cash) | 17.58 | 3.91 | 9.81 |
Investing Activities (Net Cash) | 0.01 | 0.01 | 0.01 |
Financing Activities (Net Cash) | 15.93 | 16.48 | 18.04 |
Net Cashflow | 15.44 | 2.18 | 8.97 |
Particulars (in Rs. Crores)
Revenue from operations
EBITDA
PAT
Total Assets
Share Capital
Total Borrowings
Operating Activities (Net Cash)
Investing Activities (Net Cash)
Financing Activities (Net Cash)
Net Cashflow
About Star Imaging and Path Lab Ltd
Our Company was originally incorporated as a private limited company under the Companies Act, 1956 in the name and style of Star Imaging & Path Lab Private Limited bearing Corporate Identification Number U85110DL2004PTC126679 dated May 31, 2004, issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana. Subsequently, our Company was converted into a Public Limited Company vide Special Resolution passed by the Shareholders at the Extra-Ordinary General Meeting, held on April 12, 2024, and consequently the name of our Company was changed from Star Imaging and Path Lab Private Limited to Star Imaging and Path Lab Limited vide a fresh certificate of incorporation dated September 17, 2024 issued by the Registrar of Companies, Central Processing Centre bearing CIN U85110DL2004PLC126679.
Global growth is projected at 3.3 percent both in 2025 and 2026, below the historical (2000-19) average of 3.7 percent. The forecast for 2025 is broadly unchanged from that in the October 2024 World Economic Outlook (WEO), primarily on account of an upward revision in the United States offsetting downward revisions in other major economies. Global headline inflation is expected to decline to 4.2 percent in 2025 and to 3.5 percent in 2026, converging back to target earlier in advanced economies than in emerging market and developing economies. Medium-term risks to the baseline are tilted to the downside, while the near-term outlook is characterized by divergent risks. Upside risks could lift already-robust growth in the United States in the short run, whereas risks in other countries are on the downside amid elevated policy uncertainty. Policy-generated disruptions to the ongoing disinflation process could interrupt the pivot to easing monetary policy, with implications for fiscal sustainability and financial stability. Managing these risks requires a keen policy focus on balancing trade-offs between inflation and real activity, rebuilding buffers, and lifting medium-term growth prospects through stepped-up structural reforms as well as stronger multilateral rules and cooperation. Forces Shaping the Outlook: The global economy is holding steady, although the degree of grip varies widely across countries. Global GDP growth in the third quarter of 2024 was 0.1 percentage point below that predicted in the October 2024 WEO, after disappointing data releases in some Asian and European economies. Growth in China, at 4.7 percent in year-over-year terms, was below expectations. Faster-than-expected net export growth only partly offset a faster-than-expected slowdown in consumption amid delayed stabilization in the property market and persistently low consumer confidence. Growth in India also slowed more than expected, led by a sharper-than-expected deceleration in industrial activity. Growth continued to be subdued in the euro area (with Germany's performance lagging that of other euro area countries), largely reflecting continued weakness in manufacturing and goods exports even as consumption picked up in line with the recovery in real incomes. In Japan, output contracted mildly owing to temporary supply disruptions. By contrast, momentum in the United States remained robust, with the economy expanding at a rate of 2.7 percent in year-over-year terms in the third quarter, powered by strong consumption. Global disinflation continues, but there are signs that progress is stalling in some countries and that elevated inflation is persistent in a few cases. The global median of sequential core inflation has been just slightly above 2 percent for the past few months. Nominal wage growth is showing signs of moderation, alongside indications of continuing normalization in labor markets. Although core goods price inflation has fallen back to or below trend, services price inflation is still running above pre-COVID-19 averages in many economies, most notably the United States and the euro area. Pockets of elevated inflation, reflecting a range of idiosyncratic factors, also persist in some emerging market and developing economies in Europe and Latin America. Where inflation is proving moresticky, central banks are moving more cautiously in the easing cycle while keeping a close eye on activity and labor market indicators as well as exchange rate movements. A few central banks are raising rates, marking a point of divergence in monetary policy. Global financial conditions remain largely accommodative, again with some differentiation across jurisdictions (see Box 1). Equities in advanced economies have rallied on expectations of more business friendly policies in the United States. In emerging market and developing economies, equity valuations have been more subdued, and a broad-based strengthening of the US dollar, driven primarily by expectations of new tariffs and higher interest rates in the United States, has kept financial conditions tighter. Economic policy uncertainty has increased sharply, especially on the trade and fiscal fronts, with some differentiation across countries (Figure 1). Expectations of policy shifts under newly elected governments in 2024 have shaped financial market pricing in recent months. Bouts of political instability in some Asian and European countries have rattled markets and injected additional uncertainty regarding stalled progress on fiscal and structural policies. Geopolitical tensions, including those in the Middle East, and global trade frictions remain elevated.
The company operates a diagnostic testing network, NABL accredited, delivering pathology, radiology, Cardiology, and Neurology services in Delhi (B2C, B2B & B2G model), Uttar Pradesh (B2G model), and Nasik (B2G Model) regions of India.
Star Imaging and Path Lab Ltd IPO Key Points
Strengths
- Integrated diagnostics provider with one-stop solution offering pathology and radiology services.
- Established presence and proven track record.
- Dedicated management team with significant industry experience.
Risk
- Our Company, Promoter and Directors are parties to certain legal proceedings. Any adverse decision in such proceedings may have a material adverse effect on our business, results of operations and financial condition.
- There have been instances in the past where we have not made regulatory filing of Consolidated Financials of our Company with RoC.
- Our Company has reported certain negative cash flows from its operating activity, investing activity and financing activity, details of which are given below.
Strategy
- Continue to expand presence across India.
- Expand our offering of diagnostic services with a focus on specialized diagnostics.
- Integrated diagnostics provider with one-stop solution offering pathology and radiology services.
- Established presence and proven track record.
- Dedicated management team with significant industry experience.
How To Apply for Star Imaging and Path Lab Ltd IPO Online?
Step 1:
Log in to the BlinkX stock market app and click ‘IPO’ in the Xplore section.
Step 2:
From the list of open IPOs, select the IPO you want to invest.
Step 3:
Go through the IPO details like lot size, price band, about the company, etc.
Step 4:
Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.
Step 5:
Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.